ARTICLE | Clinical News
Elite regulatory update
March 8, 1999 8:00 AM UTC
ELIP's Elite Laboratories Inc. subsidiary received U.S. Patent No. 5,871,776 covering an oral controlled-release formulation of nifedipine, a calcium channel blocker to treat hypertension. ...